Ozempic Users Show Sharp Drops in Depression and Anxiety

A major study published in The Lancet Psychiatry found that GLP-1 medication users had significantly fewer psychiatric hospital visits, less work absence due to mental health, and lower rates of substance use disorders.

The mental health benefits of GLP-1 medications have been whispered about in clinical circles for years. Patients would mention feeling "lighter" emotionally, not just physically. Doctors noticed mood improvements that seemed disproportionate to the weight loss alone. Now, a large-scale study has put real numbers to those observations. ScienceDaily

Published in The Lancet Psychiatry in 2026, a national cohort study from Sweden analyzed outcomes in people with depression and anxiety who used GLP-1 receptor agonists. The findings were, by the researchers' own admission, stronger than expected.

What the Study Found

The study used Swedish national healthcare registries to track mental health outcomes in people prescribed GLP-1 medications. The researchers specifically looked at people who already had diagnoses of depression or anxiety — a population at high risk for worsening symptoms and psychiatric crises.

The results showed that GLP-1 medication use was associated with fewer psychiatric hospital visits, reduced time off work due to mental health issues, and lower rates of substance use disorders. The effects were consistent across different subgroups and remained significant after adjusting for potential confounders. Lancet Psychiatry 2026

Why GLP-1s Might Improve Mental Health

The researchers noted several possible explanations for the findings:

Direct neurobiological effects. GLP-1 receptors are present in brain regions involved in mood regulation, including areas of the reward system. Activation of these receptors may directly influence neurotransmitter pathways involved in depression and anxiety.

Reduced alcohol consumption. Previous research has shown GLP-1 medications reduce alcohol use. Since alcohol problems frequently worsen depression and anxiety, this could produce downstream mood benefits.

Weight loss and body image. Significant weight loss can improve self-esteem, social participation, physical activity levels, and overall quality of life — all of which are protective factors for mental health.

Improved metabolic health. Better blood sugar control, reduced inflammation, and improved cardiovascular function all contribute to overall well-being and can indirectly improve mood.

Safety Reassurance

These findings are particularly important because earlier concerns had been raised about potential psychiatric side effects of GLP-1 medications. A separate large UK study comparing GLP-1 users to other diabetes medication users found no increased risk of suicidal ideation (HR 1.03), self-harm (HR 0.92), or suicide (HR 0.75) — even among patients with pre-existing psychiatric conditions. PMC

Ready to Get Started?

These verified telehealth providers offer GLP-1 programs with medical oversight and home delivery:

Affiliate Disclosure: Some provider links on this page are affiliate links. If you sign up through these links, we may receive compensation at no additional cost to you. This does not influence our editorial content or provider selection.